Amy C. Peterson, CMO, Immuno-oncology at BeiGene, Ltd. (BGNE), sold 14,511 shares at $122.86 ($1.8M) on 2018-11-08, disclosed to the SEC on 2018-11-13.
Open-market sale of $1.8M BGNE by CMO, Immuno-oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.86 | 466 | $57K | 3.1% |
| 2 | $124.48 | 2,423 | $302K | 16.5% |
| 3 | $126.08 | 3,949 | $498K | 27.2% |
| 4 | $126.72 | 7,673 | $972K | 53.2% |
| Total | $126.05 avg | 14,511 | $1.8M | 100% |
| Filing → |
| CTMX | SELL | 2022-07-21 | $11K | — | Filing → |
| BGNE | SELL | 2018-12-19 | $4.5M | — | Filing → |
| BGNE | SELL | 2018-12-19 | $1.4M | — | Filing → |